Journal of Investment Strategies

Risk.net

Sign prediction and sign regression

Weige Huang

  • The model prediction signs matter a lot in finance, especially for investment strategy constructions.
  • This paper proposes a new approach termed "sign regression" in which the loss function considers errors in prediction signs and the sizes and signs of the residuals in the model prediction simultaneously.
  • This paper shows that sign regression generates lower Sharpe ratios than ordinary least squares for most assets. However, sign regression can do better for some assets.

Intuitively, model-predicted signs matter a lot in finance, especially for investment strategy constructions. This paper proposes an approach whereby the loss function regularizes the errors in prediction in different ways. In particular, the loss function considers errors in predicted signs and the sizes and signs of the residuals in the model prediction simultaneously. Less weight is given to residuals with correctly predicted signs, while more weight is assigned to residuals with wrongly predicted signs. This is important because agents make decisions according to model predictions, especially the signs of the predictions. At the same time, larger residuals are penalized more and smaller residuals are penalized less. The signs of the residuals are considered in the loss function because they also affect decision-making processes. This paper proposes a new approach, termed “sign regression”, which takes these considerations into account. We show that ordinary least squares estimators generate better Sharpe ratios than sign regression does for most of the assets studied in this paper. However, sign regression can perform better for some assets.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here